日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma

纳武利尤单抗联合伊匹木单抗治疗晚期食管鳞状细胞癌的安全性和短期疗效

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01162-3
Shiraishi, Kazuhiro; Yamamoto, Shun; Yoshinami, Yuri; Ogura, Nozomu; Itoyama, Mai; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Real-world comparison between neoadjuvant FLOT therapy and DCF therapy for resectable esophagogastric junction adenocarcinoma

新辅助FLOT方案与DCF方案治疗可切除食管胃交界处腺癌的真实世界比较

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01168-x
Shiraishi, Kazuhiro; Yamamoto, Shun; Hirose, Toshiharu; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Hashimoto, Taiki; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Safety and short-term efficacy of neoadjuvant FLOT therapy in cisplatin-unfit patients with resectable esophageal squamous cell carcinoma

新辅助FLOT方案治疗不适合顺铂治疗的可切除食管鳞状细胞癌患者的安全性和短期疗效

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01160-5
Yoshinami, Yuri; Yamamoto, Shun; Shiraishi, Kazuhiro; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Hashimoto, Taiki; Kashihara, Tairo; Daiko, Hiroyuki; Kato, Ken
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistance.

癌细胞中IL10RB的表达与进化改变有关，从而巩固治疗耐药性。

期刊:
影响因子:
doi:10.1038/s44276-026-00211-3
Kudo-Saito Chie, Ozawa Hiroki, Imazeki Hiroshi, Masuda Hitomi, Takaiwa Aki, Toyoura Masayoshi
肿瘤
肿瘤免疫
治疗耐药
IL10
细胞生物学
发表日期：2026
文献求助 收藏

IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer

IL33-ST2轴是晚期胃癌抗PD-1治疗疗效的预测性生物标志物

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07145-3
Kudo-Saito, Chie; Imazeki, Hiroshi; Nagashima, Kengo; Shoji, Hirokazu; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Ichikawa, Hitoshi; Boku, Narikazu
胃癌
肿瘤
肿瘤免疫
IL3
PD-1
发表日期：2025
文献求助 收藏

The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer.

FSTL1-DIP2A 轴是预测晚期胃癌抗 PD-1 治疗效果的重要生物标志物。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04239-1
Kudo-Saito Chie, Imazeki Hiroshi, Nagashima Kengo, Shoji Hirokazu, Tsugaru Kai, Takahashi Naoki, Kawakami Takeshi, Amanuma Yusuke, Wakatsuki Takeru, Nagashima Fumio, Narita Yukiya, Yamamoto Yoshiyuki, Kizawa Rika, Muro Kei, Boku Narikazu
胃癌
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer

外周SNCA(+)细胞是晚期胃癌患者接受纳武利尤单抗治疗预后不良的因素

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-03817-0
Kudo-Saito, Chie; Imazeki, Hiroshi; Nagashima, Kengo; Shoji, Hirokazu; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Boku, Narikazu
胃癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Predictors of Disengagement and Loss to Follow-Up of Intravitreal Injection for Neovascular Age-Related Macular Degeneration in a Real-World Clinical Setting: Post Hoc Analysis of the Multicenter Survey from the Japanese Clinical Retinal Study (J-CREST) Group

真实世界临床环境中新生血管性年龄相关性黄斑变性玻璃体内注射治疗的脱落和失访预测因素：日本临床视网膜研究（J-CREST）组多中心调查的事后分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14061803
Imazeki, Masaya; Takeuchi, Masaru; Yasukawa, Tsutomu; Terasaki, Hiroto; Yamamoto, Yuki; Jujo, Tatsuya; Wakuta, Makiko; Matsubara, Hisashi; Mitamura, Yoshinori; Kato, Aki; Kondo, Mineo; Kimura, Kazuhiro; Takagi, Hitoshi; Gomi, Fumi; Sakamoto, Taiji
CREST
REST
发表日期：2025
文献求助 收藏

Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer

抗生素辅助粪便微生物移植联合免疫疗法治疗食管癌和胃癌的可行性研究

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2599371
Yoshinami, Yuri; Yamaguchi, Shotaro; Shoji, Hirokazu; Okita, Natsuko; Takamaru, Hiroyuki; Hirose, Toshiharu; Hirano, Hidekazu; Takashima, Atsuo; Imazeki, Hiroshi; Yamamoto, Shun; Koyama, Shohei; Ishikawa, Dai; Terauchi, Jun; Tanaka, Kazuki; Ogawa, Kana; Watanabe, Hikaru; Kato, Ken
胃癌
肿瘤
肿瘤免疫
微生物学
食管癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Could combination immunotherapy give light to resectable esophageal squamous cell carcinoma?

联合免疫疗法能否为可切除的食管鳞状细胞癌带来新的希望？

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-24-1535
Shiraishi, Kazuhiro; Yamamoto, Shun; Imazeki, Hiroshi; Kato, Ken
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏